Cargando…

Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver

BACKGROUND: HCC predominantly develops in the condition of chronic inflammation that has led to liver cirrhosis. A small proportion of patients with HCC is diagnosed in the non-cirrhotic liver (NCL). Data on patients with HCC in NCL in advanced stages are scarce. METHODS: A retrospective analysis wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schütte, Kerstin, Schulz, Christian, Poranzke, Janine, Antweiler, Kai, Bornschein, Jan, Bretschneider, Tina, Arend, Jörg, Ricke, Jens, Malfertheiner, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098694/ https://www.ncbi.nlm.nih.gov/pubmed/24990270 http://dx.doi.org/10.1186/1471-230X-14-117

Ejemplares similares

Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization
por: Öcal, Osman, et al.
Publicado: (2021)

Circulating Cell-Free DNA Combined to Magnetic Resonance Imaging for Early Detection of HCC in Patients with Liver Cirrhosis
por: Alunni-Fabbroni, Marianna, et al.
Publicado: (2021)

Evaluation of fibrosis in cirrhotic elderly patients with HCC
por: Pesce, A, et al.
Publicado: (2011)

NMR-Based Lipid Metabolite Profiles to Predict Outcomes in Patients Undergoing Interventional Therapy for a Hepatocellular Carcinoma (HCC): A Substudy of the SORAMIC Trial
por: Geyer, Thomas, et al.
Publicado: (2021)

In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC
por: Ding, Bisha, et al.
Publicado: (2019)

Non-Cirrhotic Liver is Associated with Poor Prognosis of Hepatocellular Carcinoma: A Literature Review
por: Liu, Yan, et al.
Publicado: (2019)

Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial
por: Seidensticker, Max, et al.
Publicado: (2023)

Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers
por: Renzulli, Matteo, et al.
Publicado: (2022)

Image-guided high-dose-rate brachytherapy of malignancies in various inner organs – technique, indications, and perspectives
por: Bretschneider, Tina, et al.
Publicado: (2016)

Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors
por: Franck, Martin, et al.
Publicado: (2020)

US-Based Deep Learning Model for Differentiating Hepatocellular Carcinoma (HCC) From Other Malignancy in Cirrhotic Patients
por: Zhou, Hang, et al.
Publicado: (2021)

Phospholipid profiles and hepatocellular carcinoma risk and prognosis in cirrhotic patients
por: Cotte, Alexia Karen, et al.
Publicado: (2019)

Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC
por: SALVI, ALESSANDRO, et al.
Publicado: (2012)

Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

The role of the gastric bacterial microbiome in gastric cancer: Helicobacter pylori and beyond
por: Schulz, Christian, et al.
Publicado: (2019)

Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial
por: Öcal, Osman, et al.
Publicado: (2021)

Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study
por: Morisco, Filomena, et al.
Publicado: (2021)

NF-Y Overexpression in Liver Hepatocellular Carcinoma (HCC)
por: Bezzecchi, Eugenia, et al.
Publicado: (2020)

Functional and Topological Properties in Hepatocellular Carcinoma Transcriptome
por: Drozdov, Ignat, et al.
Publicado: (2012)

Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC
por: Sydor, Svenja, et al.
Publicado: (2020)

Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients
por: Dalbeni, Andrea, et al.
Publicado: (2023)

Circulating miR-21-5p level has limited prognostic value in patients with hepatocellular carcinoma and is influenced by renal function
por: Franck, Martin, et al.
Publicado: (2020)

A rare presentation of hepatocellular carcinoma in non-cirrhotic liver
por: Kabbage, Lamia, et al.
Publicado: (2017)

Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
por: Desai, Aakash, et al.
Publicado: (2019)

The Combination of AFP and “Up-To-Seven” Criteria May Be a Better Strategy for Liver Transplantation in Chinese Cirrhotic HCC Patients
por: Zhang, Da-li, et al.
Publicado: (2022)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial
por: Geyer, Thomas, et al.
Publicado: (2022)

Palliative Liver Radiotherapy (RT) for Symptomatic Hepatocellular Carcinoma (HCC)
por: Yeung, Cynthia S. Y., et al.
Publicado: (2020)

Microplastics detected in cirrhotic liver tissue
por: Horvatits, Thomas, et al.
Publicado: (2022)

Regional Ischemic Preconditioning Has Clinical Value in Cirrhotic HCC Through MAPK Pathways
por: Wang, Liming, et al.
Publicado: (2018)

Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized Therapy
por: Huang, Daniel Q., et al.
Publicado: (2020)

Hepatocellular Carcinomas in Cirrhotic and Noncirrhotic Human Livers Share Angiogenic Characteristics
por: Zeng, Wenjiao, et al.
Publicado: (2010)

Hepatocellular adenoma with malignant transformation in male patients with non-cirrhotic livers
por: An, Song-Lin, et al.
Publicado: (2015)

Hepatocellular Carcinoma Arising in a Non-cirrhotic Liver with Secondary Hemochromatosis
por: Yamauchi, Ryo, et al.
Publicado: (2018)

Hepatocellular carcinoma in a non‐cirrhotic liver with a tumor thrombus
por: Sadiq, Abid M., et al.
Publicado: (2021)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020)

Atypical Hepatocellular Neoplasm With Peliosis in Cirrhotic Liver Versus Hepatocellular Carcinoma: A Diagnostic Trap
por: Gurzu, Simona, et al.
Publicado: (2015)

Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting
por: Bonferoni, Maria Cristina, et al.
Publicado: (2020)

Deal a death blow! HCC in cirrhotics – thrombotic complications: their frequency, characteristics, and risk factors
por: Mahmood, Khalid, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_svtpfugilfbhejubaaqa99cejt